Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Vaccine

• Publication date

  2005-07-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.VACCINE.2005.03.017PMID 15964484
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up

  2005cited by this paper
• Duration of Hepatitis B Immunity in Low Risk Children Receiving Hepatitis B Vaccinations From Birth

  2004cited by this paper
• Long-term persistence of anti-HBs after vaccination against HBV: an 18 year experience in health care workers.

  2004cited by this paper
• Long-term persistence of immunity to hepatitis B after vaccination during infancy in a country where endemicity is low.

  2004cited by this paper
• The decline of hepatitis B viral infection in South-Western Saudi Arabia.

  2003cited by this paper
• Molecular analysis of antigenicity and immunogenicity of a vaccine-induced escape mutant of hepatitis B virus

  2003cited by this paper
• 10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia).

  2003cited by this paper
• Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan.

  2003cited by this paper
• Hepatitis B in Italy: Where we are ten years after the introduction of mass vaccination

  2002cited by this paper
• Hepatitis B immunization and hepatocellular carcinoma: The Gambia hepatitis Intervention Study

  2002cited by this paper
• Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian children

  2002cited by this paper
• Hepatitis B Virus Infection in Children and Adolescents in a Hyperendemic Area: 15 Years after Mass Hepatitis B Vaccination

  2001cited by this paper
• Mutant hepatitis B viruses: a matter of academic interest only or a problem with far-reaching implications?

  2001cited by this paper
• Induction of strong hepatitis B virus (HBV) specific T helper cell and cytotoxic T lymphocyte responses by therapeutic vaccination in the trimera mouse model of chronic HBV infection

  2001cited by this paper
• Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy.

  2001cited by this paper
• Are booster immunisations needed for lifelong hepatitis B immunity? European Consensus Group on Hepatitis B Immunity.

  2000cited by this paper
• Effect of hepatitis B virus mutants on efficacy of vaccination.

  2000cited by this paper
• Nationwide vaccination: a success story in Taiwan.

  2000cited by this paper
• Chronic hepatitis B virus infection in Asian countries

  2000cited by this paper
• Elimination of new chronic hepatitis B virus infections: results of the Alaska immunization program.

  2000cited by this paper
• Impact of hepatitis B immunisation as part of the EPI.

  2000cited by this paper
• Vaccination against hepatitis B: Current challenges for Asian countries and future directions

  2000cited by this paper
• Persistence of antibodies to the surface antigen of the hepatitis B virus (anti-HBs) in children subjected to the Expanded Programme on Immunization (EPI), including hepatitis-B vaccine, in Thailand

  2000cited by this paper
• Comparative immunogenicity under field conditions of two recombinant hepatitis B vaccines in 8-10-year-old children.

  2000cited by this paper
• Lifelong protection against hepatitis B: the role of vaccine immunogenicity in immune memory.

  2000cited by this paper
• Long‐term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B e antigen

  1999cited by this paper
• Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children.

  1999cited by this paper
• Seroepidemiology of hepatitis B virus infection in Saudi children 8 years after a mass hepatitis B vaccination programme.

  1999cited by this paper
• Characterization of the reactivity pattern of murine monoclonal antibodies against wild‐type hepatitis B surface antigen to g145r and other naturally occurring “a” loop escape mutations

  1999cited by this paper
• Kinetics of hepatitis B surface antigen–specific immune responses in acute and chronic hepatitis B or After HBs vaccination: Stimulation of the in vitro antibody response by interferon gamma

  1999cited by this paper
• Twelve‐year follow‐up of a prospective randomized trial of hepatitis b recombinant DNA yeast vaccine versus plasma‐derived vaccine without booster doses in children

  1999cited by this paper
• Hepatitis B vaccination in high-risk infants: 10-year follow-up.

  1999cited by this paper
• LONG‐TERM IMMUNE RESPONSE OF UNIVERSAL HEPATITIS B VACCINATION IN INFANCY: A COMMUNITY‐BASED STUDY IN TAIWAN

  1999cited by this paper
• Hepatitis B vaccination in infancy in The Gambia: protection against carriage at 9 years of age.

  1999cited by this paper
• Long term immune response of universal hepatitis B vaccination in infancy: a community-based study in Taiwan.

  1999cited by this paper
• Current aspects of hepatitis B surface antigen mutants in Singapore

  1998cited by this paper
• Long-term persistence of anti-HBs after vaccination with a recombinant DNA yeast-derived hepatitis B vaccine: 8-year results.

  1998cited by this paper
• Editorial: We have a cancer vaccine – why don't we use it?

  1998cited by this paper
• Anti-HBs responses in children vaccinated with different schedules of either plasma-derived or HBV DNA recombinant vaccine.

  1997cited by this paper
• Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group.

  1997cited by this paper
• Prevention and control of hepatitis B virus infection in Singapore.

  1997cited by this paper
• Protection provided by hepatitis B vaccine in a Yupik Eskimo population--results of a 10-year study.

  1997cited by this paper
• Prevention and control of hepatitis B virus infection in Singapore.

  1997cited by this paper
• Ten-year follow-up study of neonatal hepatitis B immunization: are booster injections indicated?

  1997cited by this paper
• Hepatitis B virus infection in Singapore.

  1996cited by this paper
• Regulation of the neutralizing anti‐hepatitis B surface (HBs) antibody response in vitro in HBs vaccine recipients and patients with acute or chronic hepatitis B virus (HBV) infection

  1996cited by this paper
• Persistence of anti-HBs in children vaccinated against viral hepatitis B in the first year of life: follow-up at 5 and 10 years.

  1996cited by this paper
• Long-term efficacy of continuing hepatitis B vaccination in infancy in two Gambian villages.

  1995cited by this paper
• Cost-Effectiveness Analysis of Hepatitis B Vaccination Strategies in Catalonia, Spain

  1995cited by this paper
• Persistence of anti-HBs antibodies in health care personnel vaccinated with plasma-derived hepatitis B vaccine and response to recombinant DNA HB booster vaccine.

  1995cited by this paper
• Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen.

  1995cited by this paper
• Hepatitis B vaccination in children: Persistence of immunity at 9 years

  1994cited by this paper
• Twelve-year follow-up study of hepatitis B immunization of Senegalese infants.

  1994cited by this paper
• Integration of hepatitis B vaccine into the expanded program on immunization: The Saudi Arabian experience.

  1993cited by this paper
• Efficacy of hepatitis B vaccine in the Gambian expanded programme on immunisation.

  1993cited by this paper
• The serology of chronic hepatitis B infection revisited.

  1993cited by this paper
• Five‐year follow‐up of a prospective randomized trial of hepatitis B recombinant DNA yeast vaccine vs. plasma‐derived vaccine in children: Immunogenicity and anamnestic responses

  1993cited by this paper
• Prospects for control of hepatitis B virus infection: implications of childhood vaccination and long-term protection.

  1992cited by this paper
• The Gambia Hepatitis Intervention Study: follow-up of a cohort of children vaccinated against hepatitis B.

  1992cited by this paper
• Seroepidemiology of hepatitis B virus infection in Saudi Arabian children: a baseline survey for mass vaccination against hepatitis B.

  1992cited by this paper
• Vaccination against hepatitis B and protection against chronic viral carriage in The Gambia.

  1991cited by this paper
• Vaccination aginst chronic viral carriage in The Gambia

  1991cited by this paper
• Vaccine-induced escape mutant of hepatitis B virus.

  1990cited by this paper
• Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.

  1990cited by this paper
• Persistence of specific antibodies after hepatitis B vaccination.

  1988cited by this paper
• Hepatitis B Infection in Saudi Arabia

  1988cited by this paper
• A comprehensive programme to reduce the incidence of hepatitis B virus infection and its sequelae in Alaskan natives.

  1987cited by this paper
• Viral hepatitis and liver disease

  1984cited by this paper

• Factors Associated with the Anamnestic Immune Response Following Hepatitis B Booster Vaccination in the Elderly.

  2026cites this paper
• Long‐Term Immunity and Anamnestic Response Following Hepatitis B Vaccination: A Systematic Review and Meta‐Analysis

  2025influential citation
• Pediatric cirrhosis: special consideration for its diagnosis and management

  2025cites this paper
• Long-term protection and response to a booster dose after primary hepatitis B vaccination in people under pre-exposure prophylaxis for HIV infection.

  2025cites this paper
• Prevalence of vaccine-derived hepatitis B surface antibodies in children and adolescents in Germany: results from a population-based survey, 2014–2017

  2024cites this paper
• Lack of relationship between 25-hydoxyvitamin D concentration and a titer of antibodies to hepatitis B surface antigen in children under 12 years of age

  2022cites this paper
• Hepatitis B Vaccination: A Historical Overview with a Focus on the Italian Achievements

  2022cites this paper
• Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2

  2022cites this paper
• The positive rates of hepatitis B surface antibody in youth after booster vaccination: a 4-year follow-up study with large sample

  2021cites this paper
• Hepatitis B Vaccines

  2021cites this paper
• Levels of hepatitis B antibody titers are affected by age and doses gap time in children from a high endemic area of the western Amazon

  2021cites this paper
• Hepatitis B Virus

  2020cites this paper
• Evaluation of Hepatitis B, Hepatitis A, Measles, Rubella, Mumps and Varicella Antibody Seroprevalences in Vocational School of Health Students

  2020cites this paper
• Kinetics of Anti-Hepatitis B Surface Antigen Titers in Nurse Students after a Two-Year Follow-Up

  2020cites this paper
• Administering an additional hepatitis B vaccination dose after 18 years maintains adequate long-term protection levels in healthcare workers

  2020cites this paper
• No evidence of occult HBV infection in population born after mass vaccination

  2020cites this paper
• Porcine Circovirus 2 Genotypes, Immunity and Vaccines: Multiple Genotypes but One Single Serotype

  2020cites this paper
• Hepatitis B and pertussis antibodies in 4- to 5-year-old children previously vaccinated with different hexavalent vaccines

  2019cites this paper
• Evolution of infectious bronchitis virus in the field after homologous vaccination introduction

  2019cites this paper
• Evaluation of antibody persistence after a four-dose primary hepatitis B vaccination and anamnestic immune response in children under 6 years.

  2019cites this paper
• 25 – Hepatitis B Vaccines

  2018cites this paper
• Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis

  2018cites this paper
• Incidence of hepatitis B virus infection in young Chinese blood donors born after mandatory implementation of neonatal hepatitis B vaccination nationwide

  2018cites this paper
• Could resistant and escape variants of hepatitis B virus be a problem in the future

  2018cites this paper
• Persistence of immune memory among adults with normal and high antibody response to primary hepatitis B vaccination: Results from a five-year follow-up study in China

  2018cites this paper
• 213 – Hepatitis B and Hepatitis D Viruses

  2018cites this paper
• Booster Dose Vaccine Response among Children Who were Primary Hepatitis B Vaccine Non-Responders and Sensitive Groups Concerning Vaccine Response

  2018cites this paper
• In pursuit of control and elimination: update on hepatitis A and B epidemiology and prevention strategies

  2018cites this paper
• The Effect of Oral Levamisole Co-administration on the Level of Immune Response to Hepatitis B Vaccine in Healthy Individuals: A Randomized Clinical Trial.

  2017cites this paper
• Serological Investigation against Recombinant Hepatitis B Virus Surface Mutants in Vaccinated Healthcare Workers and HBV Chronic Carriers with Anti-HBs

  2017cites this paper
• Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease

  2017cites this paper
• Memory T cells specific for HBV enumerated by a peptide-based cultured enzyme-linked immunospot assay in healthy HBV-vaccinated subjects

  2016cites this paper
• Study of Anti-hepatitis B antibody titers in vaccinated Students of Zahedan Dental School in 2012

  2016cites this paper
• Immune Response And Anamnestic Immune Response In Children After A 3-Dose Primary Hepatitis B Vaccination.

  2016cites this paper
• Primary vaccine failure to routine vaccines: Why and what to do?

  2016cites this paper
• Booster dose vaccination for preventing hepatitis B.

  2016cites this paper
• Adverse Events Following Immunization in Viet Nam in 013 on chronic hepatitis B infection

  2016cites this paper
• Schistosoma mansoni Infection Can Jeopardize the Duration of Protective Levels of Antibody Responses to Immunizations against Hepatitis B and Tetanus Toxoid

  2016cites this paper
• Impact of Adverse Events Following Immunization in Viet Nam in 2013 on chronic hepatitis B infection☆

  2016cites this paper
• Porcine circovirus type 2 (PCV2) evolution before and after the vaccination introduction: A large scale epidemiological study

  2016cites this paper
• The Association of Pre-S/S Gene Mutations and Hepatitis B Virus Vertical Transmission

  2016cites this paper
• Hepatitis B immune status in adolescents vaccinated during infancy: A retrospective cohort study from a pediatric practice in Germany

  2016influential citation
• Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.

  2015cites this paper
• Immunization Status Against Hepatitis B Among Iranian Junior Medical, Nursing, and Obstetrics Students With Different Vaccination Patterns

  2015cites this paper
• VHPB meeting Prevention and control of Viral Hepatitis in the Baltic States: lessons learnt and the way forward

  2015cites this paper
• An “immune barrier” is formed in the placenta by hepatitis B immunoglobulin to protect the fetus from hepatitis B virus infection from the mother

  2015cites this paper
• THE COURSE OF CHRONIC HEPATITIS B IN INFANTS BORN TO MOTHERS WITH HBV-INFECTION

  2015cites this paper
• Serologic control against hepatitis B virus among dental students of the University of Granada, Spain

  2015cites this paper
• Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood

  2015cites this paper
• Hepatitis B: prevention, protection and occupational risk

  2015cites this paper
• Induced immunity against hepatitis B virus.

  2015cites this paper
• Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.

  2015cites this paper
• Seroprotection after hepatitis B vaccination in children aged 1 to 15 years in central province of Iran, Semnan

  2014cites this paper
• STUDY OF CANDIDA ALBICANS MANNOPROTIEN IMMUNOMODULATORY EFFECT ON IMMUNE RESPONSE IN MICE VACCINATED WITH HBS VACCINE

  2014cites this paper
• Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.

  2014cites this paper
• The Impact of Vaccination and Antiviral Therapy on Hepatitis B and Hepatitis D Epidemiology

  2014cites this paper
• Hepatitis B immunity in teenagers vaccinated as infants: an Italian 17-year follow-up study.

  2014cites this paper
• The persistence of anti-HBs antibody and anamnestic response 20 years after primary vaccination with recombinant hepatitis B vaccine at infancy

  2014cites this paper
• Meeting subjects Session 1 : Global Viral hepatitis prevention and control Presentation

  2014cites this paper
• Immune Response to Standard Hepatitis B Vaccination in HIV-Infected Patients

  2014cites this paper
• STUDY OF CANDIDA ALBICANS MANNOPROTIEN IMMUNOMODULATORY EFFECT ON IMMUNE RESPONSE IN MICE VACCINATED WITH HB

  2014cites this paper
• Hepatitis B Virus Antibody Levels 7 to 9 Years after Booster Vaccination in Alaska Native Persons

  2014cites this paper
• Hepatitis B vaccination policies for student healthcare workers in Europe.

  2014cites this paper
• Long-Term T-Cell-Mediated Immunologic Memory to Hepatitis B Vaccine in Young Adults Following Neonatal Vaccination.

  2014cites this paper
• Immune Memory and Immune Response in Children From Bulgaria 5–15 Years After Primary Hepatitis B Vaccination

  2013cites this paper
• Unraveling the complexity of hepatitis B virus: from molecular understanding to therapeutic strategy in 50 years.

  2013cites this paper
• Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response

  2013cites this paper
• Seroepidemiology of hepatitis B virus infection among adults in Singapore: a 12-year review.

  2013cites this paper
• Hepatitis B vaccination of adolescents: significance of non-protective antibodies.

  2013cites this paper
• Long-term response rates of successful hepatitis B vaccination in HIV-infected patients.

  2013cites this paper
• Epidemiology of HBV S-gene mutants in the Liguria Region, Italy

  2013cites this paper
• Assessment of the Immune Status among Hepatitis B Virus Vaccinated Children in Jeddah City Sanaa

  2013cites this paper
• 15 – Hepatitis B vaccines

  2013cites this paper
• Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum.

  2013cites this paper
• Sexual transmission of viral hepatitis.

  2013cites this paper
• Hepatitis B vaccination: a completed schedule enough to control HBV lifelong? Milan, Italy, 17-18 November 2011.

  2013influential citation
• Vaccines for health care personnel

  2013cites this paper
• Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.

  2012cites this paper
• Viral hepatitis: global goals for vaccination.

  2012cites this paper
• Evaluation of immune status against hepatitis B in children with thalassemia major in Egypt: A single center study

  2012cites this paper
• Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre‐S1 antigens induce broadly reactive neutralizing antibodies

  2012cites this paper
• COMPARISON OF THE EFFICACY OF HEPATITIS B VACCINATION BY DIFFERENT ROUTES OF IMMUNIZATION

  2012cites this paper
• Evaluation of immune status against hepatitis B in children with thalassemia major in Egypt : A single center study

  2012cites this paper
• A Test about the Knowledge of some concepts of Evolutionary Medicine in the Medical Field

  2011cites this paper
• Immune response to hepatitis B vaccine in health-care workers.

  2011cites this paper
• Understanding Original Antigenic Sin in Influenza with a Dynamical System

  2011cites this paper
• Seroprevalence of hepatitis B and hepatitis C markers in adolescents in Southern Brazil.

  2011cites this paper
• Factors associated with vaccine reactogenicity in school aged children and young adults following administration of two protein-based vaccines

  2011cites this paper
• Geographic and Genetic Diversity of Hepatitis B

  2011cites this paper
• Waning immunity and booster responses in nursing and medical technology students who had received plasma-derived or recombinant hepatitis B vaccine during infancy.

  2011cites this paper
• Prevalence of protective level of hepatitis B antibody 3 years after revaccination in HIV-infected children on antiretroviral therapy.

  2011cites this paper
• Routine Newborn Hepatitis B Immunization: A Review of Schedules

  2011cites this paper
• Antibody levels and immune memory 23 years after primary plasma-derived hepatitis B vaccination: results of a randomized placebo-controlled trial cohort from China where endemicity is high.

  2011cites this paper
• Computational and Theoretical Analysis of Influenza Virus Evolution and Immune System Dynamics

  2011cites this paper
• Burden and prevention of viral hepatitis in Bulgaria.

  2011cites this paper
• Concerns regarding hepatitis B vaccination and post-vaccination test among Brazilian dentists

  2010cites this paper
• Booster dose vaccination for preventing hepatitis B.

  2010cites this paper
• Boosters for hepatitis B vaccination? Need for an evidence‐based policy

  2010cites this paper
• HEPATITIS B VACCINE: IMMUNITY, EFFICACY AND TYPES

  2010cites this paper
• The response to hepatitis B vaccine: does it differ in celiac disease?

  2010cites this paper